Literature DB >> 9658089

Naturally occurring human immunodeficiency virus type 1 long terminal repeats have a frequently observed duplication that binds RBF-2 and represses transcription.

M C Estable1, B Bell, M Hirst, I Sadowski.   

Abstract

Approximately 38% of human immunodeficiency virus type 1 (HIV-1)-infected patients within the Vancouver Lymphadenopathy-AIDS Study have proviruses bearing partial 15- to 34-nucleotide duplications upstream of the NF-kappaB binding sites within the 5' long terminal repeat (LTR). This most frequent naturally occurring length polymorphism (MFNLP) of the HIV-1 5' LTR encompasses potential binding sites for several candidate transcription factors, including TCF-1alpha/hLEF, c-Ets, AP-4, and Ras-responsive binding factor 2 (RBF-2) (M. C. Estable et al., J. Virol. 70:4053-4062, 1996). RBF-2 and an apparently related factor, RBF-1, bind to at least four cis elements within the LTR which are required for full transcriptional responsiveness to protein-tyrosine kinases and v-Ras (B. Bell and I. Sadowski, Oncogene 13:2687-2697, 1996). Here we demonstrate that representative MFNLPs from two patients specifically bind RBF-2. In both cases, deletion of the MFNLP caused elevated LTR-directed transcription in cells expressing RBF-2 but not in cells with undetectable RBF-2. RBF-1, but not RBF-2, appears to contain the Ets transcription factor family member GABPalpha/GABPbeta1. Taken together with the fact that every MFNLP from a comparative study of over 500 LTR sequences from 42 patients contains a predicted binding site for RBF-2, our data suggest that the MFNLP is selected in vivo because it provides a duplicated RBF-2 cis element, which may limit transcription in monocytes and activated T cells.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9658089      PMCID: PMC109809     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  70 in total

1.  NF-kappa B: a family of inducible and differentially expressed enhancer-binding proteins in human T cells.

Authors:  J A Molitor; W H Walker; S Doerre; D W Ballard; W C Greene
Journal:  Proc Natl Acad Sci U S A       Date:  1990-12       Impact factor: 11.205

2.  Interaction of murine ets-1 with GGA-binding sites establishes the ETS domain as a new DNA-binding motif.

Authors:  J A Nye; J M Petersen; C V Gunther; M D Jonsen; B J Graves
Journal:  Genes Dev       Date:  1992-06       Impact factor: 11.361

3.  The kappaB sites in the human immunodeficiency virus type 1 long terminal repeat enhance virus replication yet are not absolutely required for viral growth.

Authors:  B K Chen; M B Feinberg; D Baltimore
Journal:  J Virol       Date:  1997-07       Impact factor: 5.103

4.  Comparison of 5' and 3' long terminal repeat promoter function in human immunodeficiency virus.

Authors:  B Klaver; B Berkhout
Journal:  J Virol       Date:  1994-06       Impact factor: 5.103

5.  Molecular and functional interactions of transcription factor USF with the long terminal repeat of human immunodeficiency virus type 1.

Authors:  F d'Adda di Fagagna; G Marzio; M I Gutierrez; L Y Kang; A Falaschi; M Giacca
Journal:  J Virol       Date:  1995-05       Impact factor: 5.103

6.  Distinct HIV-1 long terminal repeat quasispecies present in nervous tissues compared to that in lung, blood and lymphoid tissues of an AIDS patient.

Authors:  M Ait-Khaled; J E McLaughlin; M A Johnson; V C Emery
Journal:  AIDS       Date:  1995-07       Impact factor: 4.177

7.  Absence of selection of HIV-1 variants in vivo based on transcription/transactivation during progression to AIDS.

Authors:  S Delassus; A Meyerhans; R Cheynier; S Wain-Hobson
Journal:  Virology       Date:  1992-06       Impact factor: 3.616

8.  Convergence of Ets- and notch-related structural motifs in a heteromeric DNA binding complex.

Authors:  C C Thompson; T A Brown; S L McKnight
Journal:  Science       Date:  1991-08-16       Impact factor: 47.728

9.  Naturally occurring genotypes of the human immunodeficiency virus type 1 long terminal repeat display a wide range of basal and Tat-induced transcriptional activities.

Authors:  N L Michael; L D'Arcy; P K Ehrenberg; R R Redfield
Journal:  J Virol       Date:  1994-05       Impact factor: 5.103

10.  Induction of Sp1 phosphorylation and NF-kappa B-independent HIV promoter domain activity in T lymphocytes stimulated by okadaic acid.

Authors:  J Vlach; A Garcia; J M Jacqué; M S Rodriguez; S Michelson; J L Virelizier
Journal:  Virology       Date:  1995-04-20       Impact factor: 3.616

View more
  18 in total

Review 1.  A compilation of cellular transcription factor interactions with the HIV-1 LTR promoter.

Authors:  L A Pereira; K Bentley; A Peeters; M J Churchill; N J Deacon
Journal:  Nucleic Acids Res       Date:  2000-02-01       Impact factor: 16.971

2.  In vitro activation of feline immunodeficiency virus in ramified microglial cells from asymptomatically infected cats.

Authors:  A Hein; J P Martin; R Dörries
Journal:  J Virol       Date:  2001-09       Impact factor: 5.103

3.  Genetic analysis of the long terminal repeat (LTR) promoter region in HIV-1-infected individuals with different rates of disease progression.

Authors:  Eva Ramírez de Arellano; Cristina Martín; Vincent Soriano; José Alcamí; Africa Holguín
Journal:  Virus Genes       Date:  2006-12-09       Impact factor: 2.332

4.  Identification and functional analysis of a second RBF-2 binding site within the HIV-1 promoter.

Authors:  Matthew S Dahabieh; Marcel Ooms; Tom Malcolm; Viviana Simon; Ivan Sadowski
Journal:  Virology       Date:  2011-08-02       Impact factor: 3.616

5.  TFII-I regulates induction of chromosomally integrated human immunodeficiency virus type 1 long terminal repeat in cooperation with USF.

Authors:  Jiguo Chen; Tom Malcolm; Mario C Estable; Robert G Roeder; Ivan Sadowski
Journal:  J Virol       Date:  2005-04       Impact factor: 5.103

6.  Functional differences between the long terminal repeat transcriptional promoters of human immunodeficiency virus type 1 subtypes A through G.

Authors:  R E Jeeninga; M Hoogenkamp; M Armand-Ugon; M de Baar; K Verhoef; B Berkhout
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

Review 7.  Human immunodeficiency virus type 1 genetic diversity in the nervous system: evolutionary epiphenomenon or disease determinant?

Authors:  Guido van Marle; Christopher Power
Journal:  J Neurovirol       Date:  2005-04       Impact factor: 2.643

8.  Human immunodeficiency virus type 1 subtypes have a distinct long terminal repeat that determines the replication rate in a host-cell-specific manner.

Authors:  Tim van Opijnen; Rienk E Jeeninga; Maarten C Boerlijst; Georgios P Pollakis; Veera Zetterberg; Mika Salminen; Ben Berkhout
Journal:  J Virol       Date:  2004-04       Impact factor: 5.103

9.  Multiple NF-κB sites in HIV-1 subtype C long terminal repeat confer superior magnitude of transcription and thereby the enhanced viral predominance.

Authors:  Mahesh Bachu; Swarupa Yalla; Mangaiarkarasi Asokan; Anjali Verma; Ujjwal Neogi; Shilpee Sharma; Rajesh V Murali; Anil Babu Mukthey; Raghavendra Bhatt; Snehajyoti Chatterjee; Roshan Elizabeth Rajan; Narayana Cheedarla; Venkat S Yadavalli; Anita Mahadevan; Susarla K Shankar; Nirmala Rajagopalan; Anita Shet; Shanmugam Saravanan; Pachamuthu Balakrishnan; Suniti Solomon; Madhu Vajpayee; Kadappa Shivappa Satish; Tapas K Kundu; Kuan-Teh Jeang; Udaykumar Ranga
Journal:  J Biol Chem       Date:  2012-11-06       Impact factor: 5.157

10.  Higher transactivation activity associated with LTR and Tat elements from HIV-1 BF intersubtype recombinant variants.

Authors:  Gabriela Turk; Mauricio Carobene; Ana Monczor; Andrea Elena Rubio; Manuel Gómez-Carrillo; Horacio Salomón
Journal:  Retrovirology       Date:  2006-02-16       Impact factor: 4.602

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.